Cargando…
Deubiquitination in prostate cancer progression: role of USP22
Prostate cancer (PCa) is the leading cause of cancer death in men. With more therapeutic modalities available, the overall survival in PCa has increased significantly in recent years. Patients with relapses after advanced secondgeneration anti-androgen therapy however, often show poor disease progno...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516349/ https://www.ncbi.nlm.nih.gov/pubmed/34660907 http://dx.doi.org/10.20517/2394-4722.2020.23 |